Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2007
05/02/2007EP1778681A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
05/02/2007EP1778680A2 Spirocyclic cyclohexane derivatives
05/02/2007EP1778679A1 Piperazine derivatives useful for the treatment of gastrointestinal disorders
05/02/2007EP1778678A1 Enantioselective process
05/02/2007EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents
05/02/2007EP1778676A1 Hydantoin derivatives for the treatment of inflammatory disorders
05/02/2007EP1778673A1 Novel hydantoin derivatives for the treatment of obstructive airway diseases
05/02/2007EP1778672A1 Crystalline form of a biphenyl compound
05/02/2007EP1778671A1 Piperazine derivatives with ccr3 inhibiting activity
05/02/2007EP1778669A2 Kinase inhibitors
05/02/2007EP1778658A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
05/02/2007EP1778657A1 Fluorination process of protected aminothiazole
05/02/2007EP1778656A1 Benzoxazepine derivatives as selective estrogen receptor modulators
05/02/2007EP1778655A1 2 - { - 3 2 - (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes
05/02/2007EP1778653A1 Biaryl heterocyclic compounds and methods of making and using the same
05/02/2007EP1778652A2 Compositions and methods comprising proteinase activated receptor antagonists
05/02/2007EP1778648A2 Compounds useful for inhibiting chk1
05/02/2007EP1778647A1 New derivatives of 4, 5, 6, 7-tetrabromobenzimidazole and method of their preparation
05/02/2007EP1778646A1 Mercaptoimidazoles as ccr2 receptor antagonists
05/02/2007EP1778643A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor
05/02/2007EP1778642A1 5-ht7 receptor antagonosts
05/02/2007EP1778641A1 5-ht7 receptor antagonists
05/02/2007EP1778640A1 Trifluoromethyl substituted benzamides as kinase inhibitors
05/02/2007EP1778639A2 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
05/02/2007EP1778638A1 Diaryl ether beta2 adrenergic receptor agonists
05/02/2007EP1778637A2 Fkbp binding composition and pharmaceutical use thereof
05/02/2007EP1778633A1 Indoles useful in the treatment of inflammation
05/02/2007EP1778632A1 Indoles useful in the treatment of inflammation
05/02/2007EP1778628A1 Organic compounds
05/02/2007EP1778626A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
05/02/2007EP1778625A1 Non-glycosidic and non-peptidic select inhibitors, and the use thereof
05/02/2007EP1778624A1 Tyrosine derivatives as ppar-gamma-modulators
05/02/2007EP1778623A2 Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
05/02/2007EP1778622A1 Para-alkyl-substituted n-(4-hydroxy-3-methoxy-benzyl) cinnamamides and the use thereof for producing drugs
05/02/2007EP1778619A2 T type calcium channel inhibitors
05/02/2007EP1778618A2 Synthesis of triethylenetetramines
05/02/2007EP1778616A1 Alpha-ketoglutarates and their use as therapeutic agents
05/02/2007EP1778615A2 Oligomeric ketone compounds
05/02/2007EP1778361A1 Antimicrobial and/or antiviral composition and to methods for preparing and administering same
05/02/2007EP1778360A2 Compositions and methods for viscosupplementation
05/02/2007EP1778322A1 Powder inhaler featuring reduced compaction inhaler
05/02/2007EP1778294A2 Erythrosin-based antimicrobial photodynamic therapy compound and its use
05/02/2007EP1778289A1 Carrier for enteral administration
05/02/2007EP1778288A2 Deuterium depleted water (ddw) used as adjuvant in cancer therapy for cytostatics toxicity reduction
05/02/2007EP1778287A2 Combination therapy with nk3 receptor antagonists for the treatment of schizophrenia
05/02/2007EP1778286A2 Combination therapy with glatiramer acetate and riluzole
05/02/2007EP1778281A1 Vaccination of skunks and/or mongooses against rabies
05/02/2007EP1778274A2 Modulation of fiaf and the gastrointestinal microbiota
05/02/2007EP1778267A2 Compositions and methods related to heart failure
05/02/2007EP1778261A2 Compositions and methods for treatment and prevention of insulin resistance
05/02/2007EP1778256A1 Use of xenon as neuroprotectant in a neonatal subject
05/02/2007EP1778255A2 Methods and compositions to reduce tissue irritation in parenteral formulations
05/02/2007EP1778254A2 Prodrugs activated by rna-dependent dna-polymerases
05/02/2007EP1778253A1 Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors
05/02/2007EP1778252A2 Noncardiotoxic pharmaceutical compounds
05/02/2007EP1778251A2 Nucleoside phosphonate conjugates as anti hiv agents
05/02/2007EP1778250A2 Novel thiazole inhibitors of fructose 1,6-bisphosphatase
05/02/2007EP1778249A2 Nucleoside phosphonate conjugates as anti hiv agents
05/02/2007EP1778248A1 A composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
05/02/2007EP1778247A1 Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
05/02/2007EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone
05/02/2007EP1778245A2 T type calcium channel blockers and the treatment of diseases
05/02/2007EP1778244A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease
05/02/2007EP1778243A2 Substituted azepine derivatives as serotonin receptor modulators
05/02/2007EP1778242A2 Compounds and compositions as modulators of steroid hormone nuclear receptors
05/02/2007EP1778241A1 Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor
05/02/2007EP1778240A2 Dihydropteridinones for the treatment of cancer diseases
05/02/2007EP1778239A1 Adenosine a3 receptor agonists for the treatment of dry eye disorders including sjogren's syndrome
05/02/2007EP1778238A1 Dihydropteridinone infusion solution having a long shelf life
05/02/2007EP1778237A1 Use of aminopterin for treating cancer and inflammatory disorders
05/02/2007EP1778236A1 Modified pyrimidine glucocorticoid receptor modulators
05/02/2007EP1778235A2 Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
05/02/2007EP1778234A1 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
05/02/2007EP1778233A1 Intracellular receptor modulator compounds and methods
05/02/2007EP1778232A2 Methods and compositions for inhibiting, destroying, and/or inactivating viruses
05/02/2007EP1778231A1 Chemical compounds
05/02/2007EP1778230A2 Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
05/02/2007EP1778229A2 Amido compounds and their use as pharmaceuticals
05/02/2007EP1778228A2 Therapeutic compound and treatments
05/02/2007EP1778227A1 Inhalatory medicaments containing corticosteroids, betamimetic agents, and a novel anticholinergenic agent
05/02/2007EP1778226A1 Aerosol formulation for inhalation, containing an anticholinergenic agent
05/02/2007EP1778224A2 Flt3 inhibitors for immune suppression
05/02/2007EP1778223A1 Methods and compositions for reducing toxicity associated with leflunomide treatment
05/02/2007EP1778222A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
05/02/2007EP1778221A2 Ice inhibitors for the treatment of autoinflammatory diseases
05/02/2007EP1778220A1 Constrained cyano compounds
05/02/2007EP1778219A1 Ascophyllum compositions and methods
05/02/2007EP1778218A1 Cholesterol lowering supplement and low cholesterol egg produced by using the same
05/02/2007EP1778217A2 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof
05/02/2007EP1778216A1 Formulation for stimulating hair growth
05/02/2007EP1778215A1 Anticancer effect enhancer
05/02/2007EP1778214A2 Novel biphenyl compounds and their use
05/02/2007EP1778213A2 Oligomeric compounds
05/02/2007EP1778212A2 Ketogenic saccharides
05/02/2007EP1778211A1 Methods and materials for treating mental illness
05/02/2007EP1778210A2 Lipid-amino acid conjugates and methods of use
05/02/2007EP1778209A1 Methods and compositions for oral delivery of fts
05/02/2007EP1778208A1 Extended-release capsules comprising venlafaxine hydrochloride
05/02/2007EP1778207A2 Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
05/02/2007EP1778206A2 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
1 ... 3773 3774 3775 3776 3777 3778 3779 3780 3781 3782 3783 3784 3785 3786 3787 3788 3789 3790 3791 3792 3793 ... 7860